Medicine
Betiatide 1 mg powder for injection
Betiatide 1 mg powder for injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Before radiolabeling, store at controlled room temperature 20°C to 25°C (68°F…
Key facts
- Active ingredient (INN)
- Betiatide
- Brand
- Sold under the generic name
- Strength
- 1 mg
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 5 vials
- Manufacturer
- Jubilant RadiopharmaIndia
- Origin register
- US FDA, United States
- Storage
- Before radiolabeling, store at controlled room temperature 20°C to 25°C (68°F to 77°F) and protect from light. After radiolabeling with sodium pertechnetate Tc 99m injection, store vial upright in shielding to protect from radiation at room temperature 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 March 2023
- Identifiers
- DailyMed set ID d497f2a2-8e8d-4372-ba09-f8e6b22d2cf8NDC 65174-261Application NDA216820
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial | 65174-261-05 | Jubilant RadiopharmaIndia | 31 March 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Betiatide 1 mg powder for injection.
Clinical summary
Betiatide is a prescription medicine. It is available as powder for injection for intravenous use. MedsAcross supplies Betiatide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BetiatideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Technescan MAG3 prescribing information (Curium) · U.S. National Library of Medicine, DailyMed
Need Betiatide 1 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.